Our lab and others have shown that Semaphorin 4D (Sema4D) is pro-angiogenic when acting through its receptor Plexin-B1 on endothelial cells [3], [4] and may be produced by malignancies for the purposes of promoting blood vessel growth into the tumor [16]. The gene discussed is PLXNB1; the disease is neoplasm.